Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

I have to join the chorus of thanks BK.
I remember the first time GI inductions were mentioned, some were disgruntled, saying that the company was trying to go in too many directions at once. This helps make it clear that it is simply part of a plan to build upon the unique properties of this new class of antibiotic. I have to agree that there is little to none of this huge potential currently reflected in the share price. I haven't really looked at GI diseases but Leo seems to be very excited about the prospects.

Thanks again for posting his reply.

Did a quick GI disease search and I see infection and inflammation mentioned several times.

"Pancreaticobiliary Disease Treatment

Gallbladder Disease — the gallbladder is a sac (located near the liver) that stores bile produced in the liver. Conditions that slow or obstruct the flow of bile out of the gallbladder result in gallbladder disease, such as:

Gallstones (cholelithiasis)
Inflammation of the gallbladder (cholecystitis)
Infection
Obstruction

Pancreas Disease — the pancreas produces and releases insulin and glucagon into the bloodstream to keep blood sugar levels within a normal range. The pancreas also produces enzymes to aid in the digestion of fats, proteins and carbohydrates in the intestine. Disease of the pancreas include:

Pancreatitis (acute and chronic inflammation of the pancreas)
Solid tumors (malignant and non-malignant)
Cystic tumors (may be benign, pre-malignant or malignant)
Pseudocysts (a fluid collection of pancreatic enzymes)
Strictures (blockages)

Bile Duct Disease — bile ducts carry bile from the liver to the intestine, where it aids in the digestion of food. Bile duct diseases include:

Stones (choledocholithiasis)
Strictures (narrowing of a duct that prevents bile from draining)
Tumors (malignant and non-malignant)
Cysts
Cholangitis, an infection of the bile ducts